These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 187767)

  • 41. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
    Tovey MG; Dron M; Gresser I
    J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.
    Pearson GR; Vroman B; Chase B; Sculley T; Hummel M; Kieff E
    J Virol; 1983 Jul; 47(1):193-201. PubMed ID: 6306272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
    J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
    Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
    Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
    Qualtiere LF; Chase R; Vroman B; Pearson GR
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
    Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
    Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of antibodies to soluble antigen of Epstein-Barr virus-producing cells (P3HR-1) in the sera of hamadryas baboons of the high lymphoma incidence stock.
    Voevodin AF; Lapin BA; Yakovleva LA; Ponomarjova TI; Agrba VZ
    Exp Pathol (Jena); 1979; 17(9):517-20. PubMed ID: 231520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis.
    Strnad BC; Schuster TC; Hopkins RF; Neubauer RH; Rabin H
    J Virol; 1981 Jun; 38(3):996-1004. PubMed ID: 7017165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines.
    Adams A; Lidin B; Strander H; Cantell K
    J Gen Virol; 1975 Aug; 28(2):219-23. PubMed ID: 170371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
    Rabin H; Neubauer RH; Hopkins RF; Dzhikidze EK; Shevtsova ZV; Lapin BA
    Intervirology; 1977; 8(4):240-9. PubMed ID: 194867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of mitogens on the expression of Epstein-Barr virus antigens in human lymphoid cell lines.
    Tovey MG; Lenoir G; Begon-Lours J; Tapiero H; Rochette-Egly C
    J Immunol; 1979 Jul; 123(1):138-42. PubMed ID: 221589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunochemical characterization of EBV antigens detected by double immunodiffusion.
    Sternås L; Kallin B; Luka J; Klein G
    Intervirology; 1982; 17(4):208-14. PubMed ID: 6182123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
    Klein G; Clements G; Zeuthen J; Westman A
    Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on Epstein Barr virus (EBV)-related antigens: biochemical characterization and purification of EBV-determined nuclear antigen (EBNA) (author's transl)].
    Matsuo T
    Hokkaido Igaku Zasshi; 1979 Jan; 54(1):49-60. PubMed ID: 223952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.